Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)

China flag China · Delayed Price · Currency is CNY
7.52
+0.24 (3.30%)
May 20, 2026, 1:05 PM CST
Market Cap6.84B -30.8%
Revenue (ttm)510.45M -75.2%
Net Income-1.62B
EPS-1.73
Shares Out939.12M
PE Ration/a
Forward PEn/a
Dividend0.15 (2.06%)
Ex-Dividend Daten/a
Volume22,015,300
Average Volume16,914,196
Open7.28
Previous Close7.28
Day's Range7.23 - 7.61
52-Week Range6.42 - 13.48
Beta0.26
RSI56.97
Earnings DateApr 23, 2026

About SHA:603567

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China. [Read more]

Sector Healthcare
Founded 1996
Employees 2,349
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603567
Full Company Profile

Financial Performance

Financial Statements